> For those stuck in the United States, the FDA will let you get Ocrelizumab, which is basically Rituximab tweaked enough so that Genentech could get patent protection for it.
So Rituximab was never approved by the FDA? I assume it too had once been under patent, and its manufacturer would have tried to get it approved.